Clinical Trials Browser

Phase 1/2 × Unknown × Kidney Neoplasms × Clear all

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Phase 1/2 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT05108077 2022-01-14

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Phase 1/2 Unknown

Urinary Bladder Neoplasms, Kidney Neoplasms

NCT02446795 2017-01-18

QUASAR

Phase 1/2 Unknown

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

NCT02298608 2014-11-24

Efficacy and Safety of IRE for RMs

Phase 1/2 Unknown

Kidney Neoplasms

NCT00293501 2013-11-06

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Phase 1/2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms